# Ovid Therapeutics Inc.: Form 8-K, filed Jun 7, 2024

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 8-K
- Filed: 2024-06-07
- Accepted by EDGAR: Jun 7, 2024, 16:22 ET
- Period: 2024-06-06
- Accession: 0000950170-24-070673
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000095017024070673/ovid-20240607.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000095017024070673/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000095017024070673/ovid-20240607.htm

Filed Jun 7, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-070673. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.